Copyright Reports & Markets. All rights reserved.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Monoclonal Antibodies
      • 1.4.3 Immunomodulators
      • 1.4.4 Oncolytic Viral Therapies and Cancer Vaccines
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2014-2025)
      • 1.5.2 Lung
      • 1.5.3 Breast
      • 1.5.4 Colorectal
      • 1.5.5 Melanoma
      • 1.5.6 Prostate
      • 1.5.7 Head and Neck
      • 1.5.8 Ovarian
      • 1.5.9 Pancreatic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size
    • 2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions
      • 2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2014-2025)
      • 2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by by Players
      • 3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by by Players (2014-2019)
      • 3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
    • 3.3 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product/Solution/Service
    • 3.4 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2014-2019)
    • 4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 5.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in United States
    • 5.3 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 5.4 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    6 Europe

    • 6.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 6.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Europe
    • 6.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 6.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    7 China

    • 7.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 7.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in China
    • 7.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 7.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    8 Japan

    • 8.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 8.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Japan
    • 8.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 8.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 9.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Southeast Asia
    • 9.3 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 9.4 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    10 India

    • 10.1 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 10.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in India
    • 10.3 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 10.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
    • 11.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Central & South America
    • 11.3 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
    • 11.4 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

    12 International Players Profiles

    • 12.1 Aquila BioMedical
      • 12.1.1 Aquila BioMedical Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.1.5 Aquila BioMedical Recent Development
    • 12.2 BPS Bioscience, Inc.
      • 12.2.1 BPS Bioscience, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.2.5 BPS Bioscience, Inc. Recent Development
    • 12.3 Celentyx Ltd
      • 12.3.1 Celentyx Ltd Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.3.5 Celentyx Ltd Recent Development
    • 12.4 Crown Bioscience, Inc.
      • 12.4.1 Crown Bioscience, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.4.5 Crown Bioscience, Inc. Recent Development
    • 12.5 DiscoverX Corporation
      • 12.5.1 DiscoverX Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.5.5 DiscoverX Corporation Recent Development
    • 12.6 Explicyte
      • 12.6.1 Explicyte Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.6.5 Explicyte Recent Development
    • 12.7 Genscript Biotech Corporation
      • 12.7.1 Genscript Biotech Corporation Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.7.5 Genscript Biotech Corporation Recent Development
    • 12.8 HD Biosciences Co.
      • 12.8.1 HD Biosciences Co. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.8.5 HD Biosciences Co. Recent Development
    • 12.9 Horizon Discovery Group PLC
      • 12.9.1 Horizon Discovery Group PLC Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.9.5 Horizon Discovery Group PLC Recent Development
    • 12.10 ImmunXperts SA
      • 12.10.1 ImmunXperts SA Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
      • 12.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
      • 12.10.5 ImmunXperts SA Recent Development
    • 12.11 Molecular Imaging, Inc.
    • 12.12 Promega Corporation,Personalis, Inc.
    • 12.13 STC Biologics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Cancer Immunotherapy Drug Discovery Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cancer Immunotherapy Drug Discovery Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Immunotherapy Drug Discovery Outsourcing development in United States, Europe and China.

      The key players covered in this study
      Aquila BioMedical
      BPS Bioscience, Inc.
      Celentyx Ltd
      Crown Bioscience, Inc.
      DiscoverX Corporation
      Explicyte
      Genscript Biotech Corporation
      HD Biosciences Co.
      Horizon Discovery Group PLC
      ImmunXperts SA
      Molecular Imaging, Inc.
      Promega Corporation,Personalis, Inc.
      STC Biologics

      Market segment by Type, the product can be split into
      Monoclonal Antibodies
      Immunomodulators
      Oncolytic Viral Therapies and Cancer Vaccines
      Other

      Market segment by Application, split into
      Lung
      Breast
      Colorectal
      Melanoma
      Prostate
      Head and Neck
      Ovarian
      Pancreatic

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cancer Immunotherapy Drug Discovery Outsourcing status, future forecast, growth opportunity, key market and key players.
      To present the Cancer Immunotherapy Drug Discovery Outsourcing development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cancer Immunotherapy Drug Discovery Outsourcing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now